The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System is a prescription drug abuse, misuse and diversion surveillance system that collects timely product-and geographically-specific data.

 

The RADARS System measures rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. These data assist pharmaceutical companies in fulfillment of their regulatory obligations such as risk minimization action plans.

--Summary of Characteristics

 


The RADARS System includes:

þ     Multiple signal detection systems

þ     Multiple distinct features and services

þ     Prescription drug abuse, misuse and diversion rate calculation using two denominators:

o        Rates per 100,000 persons provide a community-based perspective of prescription drug abuse, misuse and diversion

o        Rates per 1,000 Unique Recipients of Dispensed Drug (URDD) accounts for availability of the prescribed product in a given community. This perspective addresses the needs of health care professionals and regulatory agencies such as the U.S. Food and Drug Administration

þ     Three-digit ZIP code level identification of location of prescription drug abuse, misuse and diversion

þ     Monitoring of 11 drug substances which include more than 100 products or subcategories, each of which may be reported on and additional drug substances can easily be added

þ     Standardized procedures and quality assurance practices ensuring the accuracy and integrity of data collection and reporting

þ     Experienced, expert analysis and consultation  

þ     Research for the benefit of the scientific community and the general public

 

History

The RADARS System was developed in 2002 by Purdue Pharma L.P. in response to increasing concerns of anticipated rates of prescription opioid abuse in the United States. In January 2006, the RADARS System became a non-profit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health and Hospital Authority. The RADARS System continues to grow and evolve in an effort to address new concerns and challenges as they arise. 

 

 

 

 

 

 

 



About the RADARS System


 

News 2.gif

 

·      Subscribe to receive RADARS System News, updates and annual meeting information.

 

·      The Second Quarter 2008 issue of RADARS System News is now available. This issue includes an overview of the second annual meeting, an interview with John Burke, president of NADDI, and an overview of the newly launched sixth signal detection system of the RADARS System. 

 

·      The Second Annual RADARS System Scientific Meeting: From Signals to Interventions took place on May 1, 2008. Click here to read the meeting summary.

 

·      Save the date! The 2009 RADARS System Annual Scientific Meeting will be held Thursday, April 23, 2009 at the Hyatt Regency in Bethesda, Maryland.



Recent Publications

Cicero TJ, et al. The Development of a Comprehensive Risk-Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS). Pain Medicine. 2007; 8:157-170.

Cicero TJ, et al. Relationship between Therapeutic Use and Abuse of Opioid Analgesics in Rural, Suburban, and Urban Locations in the United States. Pharmacoepidemiology and Drug Safety. 2007; 16:827-840.

Hughes AA, et al. Active Surveillance of Abused and Misused Prescription Opioids Using Poison Center Data: A Pilot Study and Descriptive Comparison. Clinical Toxicology. 2007; 45:144-151.

Inciardi JA, et al. The Diversion of Prescription Opioid Analgesics. Law Enforcement Executive Forum. 2007; 7.

Rosenblum A, et al.  Prescirption Opiod Abuse Among Enrollees into Methadone Maintenance Treatment. Drug and Alcohol Dependence. 2007; 90: 64-71.

Smith MY, et al. Quantifying Morbidity Associated with the Abuse and Misuse of Opioid Analgesics: A Comparison of Two Approaches. Clinical Toxicology. 2007; 45:23-30.

 

 --View all Publications



Privacy Statement  |  Terms Of Use
(c) 2006 RMPDC